Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Confirmatory Study of K-237-Multi-regional, Multi-center, Placebo Controlled, Randomized, Double Blind, Parallel Group Controlled Trial in Patients With Mild COVID-19

NCT05056883 is registered in ClinicalTrials.gov with Kowa Company, Ltd. as lead sponsor.

NCT NCT05056883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05056883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Confirmatory Study of K-237-Multi-regional, Multi-center, Placebo Controlled, Randomized, Double Blind, Parallel Group Controlled Trial in Patients With Mild COVID-19
Lead sponsor
Kowa Company, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
October 22, 2021
Completion date
August 26, 2022
Enrollment
1,030 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

covid19